We are live on ! Find out more
TWST icon

Twist Bioscience

264 hedge funds and large institutions have $2.73B invested in Twist Bioscience in 2025 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 92 increasing their positions, 79 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 26

60% more capital inflows, than outflows

Capital inflows: $390M | Capital outflows: $244M

60% more call options, than puts

Call options by funds: $3.36M | Put options by funds: $2.11M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

16% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 79

7% more funds holding

Funds holding: 247 → 264 (+17)

5.71% less ownership

Funds ownership: 116.71% → 111% (-5.7%)

Holders
264
Holders Change
+17
Holders Change %
+6.88%
% of All Funds
3.52%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
47
Increased
92
Reduced
79
Closed
26
Calls
$3.36​M
Puts
$2.11​M
Net Calls
+$1.26​M
Net Calls Change
-⁠$2.71​M

TWST Hedge Fund Activity: Q1 2025 in Review

264 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2025, worth a combined $2.73B — down 11% from $3.08B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new TWST positions and 26 closed out — a net gain of 21 holders — while 92 added to existing stakes and 79 trimmed.

The largest buyer was UBS AM, adding an estimated $71.5M. The largest seller was Marshall Wace, cutting an estimated $23.8M.

  • 264 institutional investors held Twist Bioscience (TWST) as of Q1 2025, up from 247 in Q4 2024.
  • Funds reported $2.73B of Twist Bioscience stock for Q1 2025, down 11% quarter-over-quarter.
  • 47 funds opened new Twist Bioscience positions in Q1 2025 and 26 closed out, a net change of +21 holders.
  • The largest Twist Bioscience buyer in Q1 2025 was UBS AM, an estimated $71.5M added.
  • The largest Twist Bioscience seller in Q1 2025 was Marshall Wace, an estimated $23.8M sold.

Based on aggregated 13F filings for Q1 2025.